(Total Views: 83)
Posted On: 05/19/2022 8:20:50 AM
Post# of 89085
$ALRN News Article - Aileron Therapeutics Announces First Patients Treated in Phase 1b Trial of ALRN-6924 in Patients with p53-Mutated Neoadjuvant Breast Cancer https://marketwirenews.com/news-releases/aile...15714.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
